Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project

Affiliations

¹ Laboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Via Portuense 292, Rome 00149, Italy.
² Department of Clinical Microbiology and Virology, San Camillo-Forlanini Hospital, Rome, Italy.
³ Medical Direction, San Camillo-Forlanini Hospital, Italy.
⁴ Regional Special Unit for Community Health Care (USCAR), National Institute for Infectious, Diseases "L. Spallanzani" IRCCS, Italy.
⁵ Regional Direction for Health and Social Policies, Lazio Region, Rome, Italy.
⁶ Health and Social-Health Integration Department, Health Promotion and Prevention Area, Lazio Region, Rome, Italy.
⁷ Laboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Via Portuense 292, Rome 00149, Italy. Electronic address: maria.capobianchi@inmi.it.
⁸ General Direction, San Camillo-Forlanini Hospital, Italy.
⁹ Medical Direction, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Italy.

Comment

Licia Bordi et al. J Infect. 2021 Jul.

. 2021 Jul;83(1):e8-e10.

doi: 10.1016/j.jinf.2021.05.013. Epub 2021 May 21.

¹ Laboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Via Portuense 292, Rome 00149, Italy.
² Department of Clinical Microbiology and Virology, San Camillo-Forlanini Hospital, Rome, Italy.
³ Medical Direction, San Camillo-Forlanini Hospital, Italy.
⁴ Regional Special Unit for Community Health Care (USCAR), National Institute for Infectious, Diseases "L. Spallanzani" IRCCS, Italy.
⁵ Regional Direction for Health and Social Policies, Lazio Region, Rome, Italy.
⁶ Health and Social-Health Integration Department, Health Promotion and Prevention Area, Lazio Region, Rome, Italy.
⁷ Laboratory of Virology, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Via Portuense 292, Rome 00149, Italy. Electronic address: maria.capobianchi@inmi.it.
⁸ General Direction, San Camillo-Forlanini Hospital, Italy.
⁹ Medical Direction, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Italy.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors report no declarations of interest.

Rapid Salivary Test suitable for a mass screening program to detect SARS-CoV-2: A diagnostic accuracy study.
Azzi L, Baj A, Alberio T, Lualdi M, Veronesi G, Carcano G, Ageno W, Gambarini C, Maffioli L, Saverio SD, Gasperina DD, Genoni AP, Premi E, Donati S, Azzolini C, Grandi AM, Dentali F, Tangianu F, Sessa F, Maurino V, Tettamanti L, Siracusa C, Vigezzi A, Monti E, Iori V, Iovino D, Ietto G; ASST dei Sette Laghi Rapid Salivary Test Nurse staff Research Group; Grossi PA, Tagliabue A, Fasano M. Azzi L, et al. J Infect. 2020 Sep;81(3):e75-e78. doi: 10.1016/j.jinf.2020.06.042. Epub 2020 Jun 21. J Infect. 2020. PMID: 32579988 Free PMC article. No abstract available.
Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
Agulló V, Fernández-González M, Ortiz de la Tabla V, Gonzalo-Jiménez N, García JA, Masiá M, Gutiérrez F. Agulló V, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.007. Epub 2020 Dec 9. J Infect. 2021. PMID: 33309541 Free PMC article. No abstract available.

1. Azzi L., Baj A., Alberio T., Lualdi M., Veronesi G., Carcano G. Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study. J Infect. 2020;81(3):e75–e78. doi: 10.1016/j.jinf.2020.06.042. - DOI - PMC - PubMed
1. Agulló V., Fernández-González M., Ortiz de la Tabla V. Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study. J Infect. 2021;82(5):186–230. doi: 10.1016/j.jinf.2020.12.007. - DOI - PMC - PubMed
1. Bordi L., Sberna G., Lalle E., Piselli P., Colavita F., Nicastri E. Frequency and duration of SARS-CoV-2 shedding in oral fluid samples assessed by a modified commercial rapid molecular assay. Viruses. 2020;12(10):E1184. doi: 10.3390/v12101184. - DOI - PMC - PubMed
1. Butler-Laporte G., Lawandi A., Schiller I., Yao M., Dendukuri N., McDonald E.G. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021;181(3):353–360. doi: 10.1001/jamainternmed.2020.8876. Mar. - DOI - PMC - PubMed
1. Bastos M.L., Perlman-Arrow S., Menzies D., Campbell J.R. The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: a systematic review and meta-analysis. Ann Intern Med. 2021:M20–6569. doi: 10.7326/M20-6569. Jan 12. - DOI - PMC - PubMed